Shah Capital, which owns approximately 6.7% of the outstanding common stock of Novavax, has issued an statement saying: “As a long-term strategic investor in Novavax, Shah Capital has been deeply
Shah Capital, which owns approximately 6.7% of the outstanding common stock of Novavax, has issued an statement saying: “As a long-term strategic investor in Novavax, Shah Capital has been deeply
Novavax (NASDAQ:NVAX) shares jumped by over 2% in the early session today amid major activist investor action at the biotechnology company. A Major Push Amid Share Price Slump Hedge fund
Novavax will showcase continued progress on data from its updated COVID-19 vaccine (NVX-CoV2601) and provide an overview of its influenza and COVID-19-Influenza Combination vaccine candidates at the World Vaccine Congress
Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ:NVAX). The settlement provides for a fund of $47,000,000 to
In a regulatory filing, Novavax (NVAX) disclosed that on March 21, the company, FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas, and FUJIFILM Diosynth Biotechnologies USA entered into a